Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Andrey N. Sokolov, MD PhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davidova, Nikolai M. Kapranov, Tatiana N. Obukhova, PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 4024.

https://doi.org/10.1182/blood.V128.22.4024.4024

Published: 2016

Journal Articles

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Eugene E. Zvonkov, MD PhD, Nelly G. Gabeeva, PhD, Anna K. Morozova, Olga A. Gavrilina, MD PhD, Anna A. Sidorova, MD, Daria A. Koroleva, MD, Tatiana N. Obukhova, PhD, Alla Kovrigina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5388.

https://doi.org/10.1182/blood.V128.22.5388.5388

Published: 2016

Journal Articles

Absence of High-Dose Consolidation Courses and Low Numbers of Allogeneic HSCTs Did Not Affect Overall Optimistic Results in B-Cell Precursor Ph-Negative Adult ALL Patients Treated By Non-Intensive but Non-Interruptive ALL-2009 Protocol: Data of the Russian ALL Study Group

Blood (2015) 126 (23): 2497.

https://doi.org/10.1182/blood.V126.23.2497.2497

Published: 2015

Journal Articles

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Valeri G Savchenko, MD, PhD, Alina Kokhno, MD, PhD, Elena N. Parovichnikova, MD PhD, Elena Mikhailova, MD, PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Mikhail Drokov, MDPhD, Valentina N. Dvirnyk, MD, PhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD

Blood (2015) 126 (23): 5238.

https://doi.org/10.1182/blood.V126.23.5238.5238

Published: 2015

Journal Articles

Late Clonal Disorders in Patients with Aplastic Anemia

Alina Kokhno, MD, PhD, Elena A Mikhaylova, MD PhD Prof, Zalina T. Fidarova, Elena Ustinova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa P. Mendeleeva, MD PhD, Larisa A. Kuzmina, MD PhD, Nina V. Tsvetaeva, MD PhD, Valentina N. Dvirnyk, MD, PhD, Tatiana N. Obukhova, PhD, Alla M. Kovrigina, MD PhD Prof., Elena N. Parovichnikova, MD PhD, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 4787.

https://doi.org/10.1182/blood.V126.23.4787.4787

Published: 2015

Journal Articles

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Anna E. Lukina, MD PhD, Elena A. Baryakh, MD PhD, Alla M. Kovrigina, MD PhD Prof., Eduard G. Gemdzhian, PhD, Vsevolod A. Misyurin, PhD, Sergey K. Kravchenko, MD PhD, Vladimir I. Vorobyev, MD PhD, Jana K. Mangasarova, MD PhD, Aminat U. Magomedova, MD PhD, Yuri U. Polyakov, PhD, Tatiana N. Obukhova, PhD, Eugene E. Zvonkov, MD PhD, Anna K. Morozova, MD PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 5902.

https://doi.org/10.1182/blood.V124.21.5902.5902

Published: 2014

Journal Articles

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Vladimir I. Vorobyev, MD PhD, Sergei K. Kravchenko, MD PhD, Eduard G. Gemdzhian, PhD, Jana K. Mangasarova, MD PhD, Elena Baryakh, MDPhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD, Kamil Kaplanov, Egor I. Dubrovin, MD, Ivan A Vorobjev, Prof., Natalya G. Turina, MD PhD, Valeri G. Savchenko, MD Prof.

Blood (2014) 124 (21): 1726.

https://doi.org/10.1182/blood.V124.21.1726.1726

Published: 2014

NARROW

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Absence of High-Dose Consolidation Courses and Low Numbers of Allogeneic HSCTs Did Not Affect Overall Optimistic Results in B-Cell Precursor Ph-Negative Adult ALL Patients Treated By Non-Intensive but Non-Interruptive ALL-2009 Protocol: Data of the Russian ALL Study Group

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Late Clonal Disorders in Patients with Aplastic Anemia

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Email alerts

ASH Publications

American Society of Hematology

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Absence of High-Dose Consolidation Courses and Low Numbers of Allogeneic HSCTs Did Not Affect Overall Optimistic Results in B-Cell Precursor Ph-Negative Adult ALL Patients Treated By Non-Intensive but Non-Interruptive ALL-2009 Protocol: Data of the Russian ALL Study Group

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Late Clonal Disorders in Patients with Aplastic Anemia

B-Cell Lymphoma Unclassified, Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma: A Single Center Experience of Intensive Chemotherapy with and without Auto-SCT

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only